Clinically Proven

Accuracy and equivalency in three hospital studies

  • University Hospitals Seidman Cancer Center
  • Akron Children’s Hospital Emergency Room

Earlier fever detection

In a clinical study conducted by University Hospitals Seidman Cancer Center, TempTraq was shown to detect temperature rise earlier than the Standard of Care by a median of 140.1 minutes (range of 30-180 minutes) with bone marrow transplant patients.1

1 “Feasibility of Continuous Monitoring of Body Temperature for Patients Undergoing Stem Cell Transplant or High-Dose Chemotherapy” / Ehsan Malek, MD and Nina Dambrosio, MSN, CNP / University Hospital – Seidman Cancer Center / February 2017 / 2. “Use of a Skin Patch Device to Obtain Temperature Measurements (Adult Study).” Principal Investigator: Aris Eliades, PhD, RN, CNS. Co-Investigators: Kathy Stoner, MSN, RN and Jean Frisone, BSN, CNP. Akron Children’s Hospital, November 2015.
Nurse Checking Phone

About Blue Spark Technologies

Founded in 2003, Blue Spark Technologies develops, manufactures, and markets applications powered by their proprietary thin, flexible carbon-zinc printed battery technology. Unlike most lithium and other battery chemistries, our carbon-zinc batteries contain no hazardous substances and are disposable, flexible, safe and eco-friendly.

TempTraq is an FDA Cleared Class II medical device and is Blue Spark’s flagship product. TempTraq gives Healthcare providers the first wireless continuous temperature monitor in the form of a soft comfortable disposable patch. Blue Spark believes that TempTraq can significantly improve the way temperature is measured in the clinical environment and provide clinicians a quicker, easier, and more effective way to measure temperature.

Visit Blue Spark Website